Fresco, Baby Girl -.
HRN: 22-49-16 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/15/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/15/2023
01/22/2023
IVT
25 Mg
24 Hrs
Neonatal Asphyxia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes